CluePoints Newsroom

Serving up the latest news and information about CluePoints

View all of our News Articles
May 7, 2020 in Blog, COVID-19, News

CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic

RISK MANAGEMENT SOLUTION ADDRESSES FDA, EMA, PMDA & MHRA CORONAVIRUS ADVICE King of Prussia, PA  – May 07, 2020: CluePoints, the premier provider of Risk-Based…
Read More
April 30, 2020 in Blog, COVID-19, COVID-19 Webinar

Beyond COVID-19: The New Normal in Risk-Based Monitoring (RBM) and Quality Management (RBQM)

Join our next webinar to learn first-hand how the CluePoints and Parexel partnership is driving best-in-class Risk-Based Quality Management Strategies to support clinical development. This…
Read More
April 14, 2020 in Blog, News

EPS Corporation Signs Groundbreaking Agreement To Drive Increased Quality And Safety Using CluePoints RBQM Solution

King of Prussia, PA  – April 14, 2020: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials,…
Read More
April 7, 2020 in Blog, COVID-19, Uncategorized

Early Risk Detection During the COVID-19 Crisis – Your Questions Answered

On Tuesday, March 31, 2020, CluePoints delivered a webinar centred around the critical importance of early risk detection. Our presenter also shared insights on how…
Read More
April 6, 2020 in Blog, COVID-19, News

CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies

Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA  – April 06, 2020: CluePoints, the premier provider of Risk-Based…
Read More
April 1, 2020 in Blog, COVID-19, COVID-19 Webinar, News

Webinar Recording: The Critical Importance of Early Risk Detection with a Special Feature Addressing COVID-19

We're delighted to announce that the recording for our COVID-19 webinar has been posted! The clinical research industry is in the midst of adopting Risk-Based…
Read More
March 30, 2020 in Blog, COVID-19

Complimentary COVID-19 Risk Assessment Package Available To All at No Cost

As advised in the coronavirus guidances recently issued by FDA, EMA, and MHRA, it is important to perform a fresh risk assessment for each study…
Read More
March 18, 2020 in Blog, News

CluePoints’ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations

MITIGATING THE IMPACT ON SITE MONITORING EFFORTS DUE TO COVID-19 King of Prussia, PA  – March 18, 2020: CluePoints, the premier provider of Risk-Based Trial…
Read More
March 17, 2020 in Blog

Registration Open for our Risk-Based Quality Management Insights Webinar

Please join us for our March 31, 2020 webinar: RBQM Insights - Understanding the Critical Importance of Early Risk Detection (With a Special Feature Addressing…
Read More
February 25, 2020 in Blog

Risk-Based Quality Management – It’s now a Question of “how” Rather than “if”

Risk-based quality management (RBQM) solutions offer sponsors and CROs a better way of detecting and managing risks that may impact the outcome of clinical trials.…
Read More

Events

Find out where we’re headed next.

Featured Whitepaper

ICH E6 (R2)
Summary
Paper

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)
Webinar
Series

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.

2,500

Platform Users

350

Studies De-Risked

15,000

Issues Detected